Monday, 26 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
CompanyDeals

Redpine Medical Raises ‘Hundreds of Millions’ in Series C Financing Round

January 27, 2025
CompanyDrug

Yipinhong’s AR882 Receives NMPA Approval for Gout Clinical Trial

January 27, 2025
CompanyDrug

Shaanxi Panlong Receives Patents for Coronavirus 3CL Protease Inhibitor

January 27, 2025
CompanyDeals

Sibionics Raises RMB 500 Million in Series D Financing Round

January 27, 2025
CompanyDeals

Waker Bioscience Raises Angel Funding for ISA Technology Upgrades

January 27, 2025
Drug

InnoCare Receives CDE Approval for Phase II Trial of Orelabrutinib Combination

January 27, 2025
CompanyDeals

Ronovo Surgical Raises Pre-Series B Funding for Surgical Robot Development

January 27, 2025
CompanyDeals

PingAn Good Doctor Partners to Establish Lifestyle Medicine

January 27, 2025
CompanyDeals

JW Therapeutics Collaborates with Juno for DLL3 CAR-T Therapy Development

January 27, 2025
CompanyDeals

Mabwell Bioscience Licenses Biosimilars to Russian Firm Binnopharm

January 27, 2025
CompanyDrug

Sirnaomics’ Lead Candidate STP707 Shows Promising Phase I Data

January 27, 2025
CompanyDrug

Kira Pharmaceuticals Gains NMPA and TGA Approvals for KP104 Phase II Study

January 27, 2025
1 2 … 6 7 8 9 10 … 22 23
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up